Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Aprea Therapeutics AB
AB
Active
Org 5566312285
Märsta
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2002 · 23 years old
1 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Aprea Therapeutics AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
0M
-1M
-1M
2020: 0M
0M
2020
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
EBITDA
SEK millions
0M
-61M
-121M
-182M
-243M
2020: -195M
-195M
2020
2021: -114M (+42% vs 2020)
-114M
+42%
2021
2022: -62M (+46% vs 2021)
-62M
+46%
2022
2023: -6M (+90% vs 2022)
-6M
+90%
2023
2024: -3M (+50% vs 2023)
-3M
+50%
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
0
0
191
165
159
Staff expenses
—
—
—
—
—
EBITDA
−2 519
−5 662
−61 903
−114 236
−194 545
Depreciation & amort.
−0
−0
−45
−69
−110
EBIT
−2 519
−5 662
−61 948
−114 305
−194 655
Net financials
214
270
22
2 724
−8 206
Profit before tax
−2 305
−5 392
−61 926
−111 581
−202 861
Tax
−0
−0
−0
−0
−0
Net profit
−2 305
−5 392
−61 926
−111 581
−202 861
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
7 787
17 503
17 860
60 714
167 645
Equity
655
9 518
8 352
16 745
76 236
Long-term debt
0
0
0
0
0
Short-term debt
7 133
7 986
9 508
42 883
88 338
Total debt
7 133
7 986
9 508
42 883
88 338
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2020
2024
Equity ratio
8,4 %
This company
38,2 %
Market median
This company
Market median
78% below market
2020
2024
Return on equity
−351,9 %
This company
18,4 %
Market median
This company
Market median
>999% below market
2020
2024
Net profit margin
<−999 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2020
2024
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2020
2024
Debt / equity
10,89×
This company
0,62×
Market median
This company
Market median
>999% above market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Aprea Therapeutics AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
